RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/31519767http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/31519767http://www.w3.org/2000/01/rdf-schema#comment"Tamoxifen has been clinically used in treating estrogen receptor (ER)-positive breast cancer for over 30 years. The most challenging aspect associated with tamoxifen therapy is the development of resistance in initially responsive breast tumors. We applied a parallel-reaction monitoring (PRM)-based quantitative proteomic method to examine the differential expression of kinase proteins in MCF-7 and the isogenic tamoxifen-resistant (TamR) cells. We were able to quantify the relative protein expression levels of 315 kinases, among which hexokinase 2 (HK2) and mTOR were up-regulated in TamR MCF-7 cells. We also observed that the TamR MCF-7 cells exhibited elevated rate of glycolysis than the parental MCF-7 cells. In addition, we found that phosphorylation of S6K - a target of mTOR - was much lower in TamR MCF-7 cells, and this phosphorylation level could be restored upon genetic depletion or pharmacological inhibition of HK2. Reciprocally, the level of S6K phosphorylation was diminished upon overexpression of HK2 in MCF-7 cells. Moreover, we observed that HK2 interacts with mTOR, and this interaction inhibits mTOR activity. Lower mTOR activity led to augmented autophagy, which conferred resistance of MCF-7 cells toward tamoxifen. Together, our study demonstrates that elevated expression of HK2 promotes autophagy through inhibiting the mTOR-S6K signaling pathway and results in resistance of MCF-7 breast cancer cells toward tamoxifen; thus, our results uncovered, for the first time, HK2 as a potential therapeutic target for overcoming tamoxifen resistance."xsd:string
http://purl.uniprot.org/citations/31519767http://purl.org/dc/terms/identifier"doi:10.1074/mcp.ra119.001576"xsd:string
http://purl.uniprot.org/citations/31519767http://purl.uniprot.org/core/author"Dai X."xsd:string
http://purl.uniprot.org/citations/31519767http://purl.uniprot.org/core/author"Li L."xsd:string
http://purl.uniprot.org/citations/31519767http://purl.uniprot.org/core/author"Liu X."xsd:string
http://purl.uniprot.org/citations/31519767http://purl.uniprot.org/core/author"Wang Y."xsd:string
http://purl.uniprot.org/citations/31519767http://purl.uniprot.org/core/author"Huang M."xsd:string
http://purl.uniprot.org/citations/31519767http://purl.uniprot.org/core/author"Miao W."xsd:string
http://purl.uniprot.org/citations/31519767http://purl.uniprot.org/core/date"2019"xsd:gYear
http://purl.uniprot.org/citations/31519767http://purl.uniprot.org/core/name"Mol Cell Proteomics"xsd:string
http://purl.uniprot.org/citations/31519767http://purl.uniprot.org/core/pages"2273-2284"xsd:string
http://purl.uniprot.org/citations/31519767http://purl.uniprot.org/core/title"Elevated Hexokinase II Expression Confers Acquired Resistance to 4-Hydroxytamoxifen in Breast Cancer Cells."xsd:string
http://purl.uniprot.org/citations/31519767http://purl.uniprot.org/core/volume"18"xsd:string
http://purl.uniprot.org/citations/31519767http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/31519767
http://purl.uniprot.org/citations/31519767http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/31519767
http://purl.uniprot.org/uniprot/#_P52789-mappedCitation-31519767http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31519767
http://purl.uniprot.org/uniprot/#_A8K2U2-mappedCitation-31519767http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31519767
http://purl.uniprot.org/uniprot/#_A0A8V8TQ52-mappedCitation-31519767http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31519767
http://purl.uniprot.org/uniprot/#_B4DZD5-mappedCitation-31519767http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31519767
http://purl.uniprot.org/uniprot/#_B3KX59-mappedCitation-31519767http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31519767
http://purl.uniprot.org/uniprot/#_B4E2H2-mappedCitation-31519767http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31519767
http://purl.uniprot.org/uniprot/#_P42345-mappedCitation-31519767http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31519767
http://purl.uniprot.org/uniprot/#_Q53QX9-mappedCitation-31519767http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31519767
http://purl.uniprot.org/uniprot/#_Q53SG7-mappedCitation-31519767http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31519767